Down Syndrome Clinical Trial
Official title:
Role of Sleep Apnea in the Neuropsychological Function in Down Syndrome People
This is the first study about Neuropsychological function and OSAS in Taiwan. Although the correlation between OSAS and neuropsychological abnormalities had been reported, it is worth to understand more about the detailed domains that involved in our cohort. After this, investigators can dissect the cause of mental retardation in DS and help for further treatment strategies.
Down Syndrome (DS) is the most common cause of mental retardation with incidence of 1 in 848
(Lin, Hu et al. 1991). Although prenatal Down syndrome and Amniocentesis had been applied for
years, in the survey of 2005, current birth incidence of DS is 1.6 in 10,000 live birth,
meaning a 30-50 new cases per year (Jou, Kuo et al. 2005). Patients with DS will have
multisystemic manifestations including short stature, mental retardation, dysmorphism,
congenital heart disease, congenital anomaly of gastrointestinal and genitourinary tract,
abnormal endocrine function, leukemia and leukemoid reaction. Beside mental retardation,
other anomalies could be treated or controlled by current medical care. The IQ of DS is
around 20-80 with significant cognitive, language, and behavior problems (Dierssen,
Ortiz-Abalia et al. 2006).
In addition, obstructive sleep apnea syndrome (OSAS) had been observed in DS people with
prevalence about 45-79% in the literature (de Miguel-Diez, Villa-Asensi et al. 2003; Dyken,
Lin-Dyken et al. 2003; Shott, Amin et al. 2006; Fitzgerald, Paul et al. 2007), which is much
higher than the 1-3% prevalence rate in general population (Holmes 1993; Gislason and
Benediktsdottir 1995). The reasons of DS people prone to have OSAS are due to the combination
of anatomical and physiological factors. In DS people, facial dysmorphism (midfacial
hypoplasia, mandibular hypoplasia), macroglossia, small hypopharynx, pharyngeal hypotonia,
tonsil and adenoid enlargement, obesity, laryngomalacia, and tracheomalacia contributed to
upper airway obstructions in DS people (Trois, Capone et al. 2009; Pandit and Fitzgerald
2012). In addition, DS people has increased incidence of lower respiratory tract diseases
including gastroesophageal reflux, immunological dysfunction, tracheal bronchus, airway
malacia, congenital heart disease, and pulmonary hypoplasia, which will predispose to OSAS.
While growing up, DS people still have generalized hypotonia with increasing risk of
developing hypothyroidism and obesity, which are also risk factors for OSAS (Trois, Capone et
al. 2009).
It has been noted that sleep disordered breathing is associated with neurocognitive deficit,
particularly of memory, learning, attention, hyperactivity, executive functioning, cognitive
capacity, and poor school performance (Beebe 2006; Pandit and Fitzgerald 2012). And a number
of studies have reported improved attention, executive functioning, analytical thinking,
verbal functioning, memory and academic progress at 6-12 months post- adenotonsillectomy
(Chervin, Ruzicka et al. 2006). In DS, study demonstrated that a higher number of apneic
episodes on polysomnography was correlated to the decreased visuoperceptual skill in DS
(Andreou, Galanopoulou et al. 2002). Similarly, presence of snoring in DS was associated with
a much higher rate of disruptive school behavior than without snore (Carskadon, Pueschel et
al. 1993). Although learning disability and memory defect had been globally known in DS, the
behavior, cognitive, and developmental impairment caused by OSAS is especially concerning
because it might adversely affect their ability, even the social adaptation (Rihtman,
Tekuzener et al. 2010) . Therefore, investigators would like to know the correlation between
severity of OSAS and Neurocognitive and behavior in DS people in Taiwan. Also, investigators
would like to follow the Neurocognitive and behavior changes in those who had been treated
for OSAS, including tonsillectomy or Bilevel Positive Airway Pressure.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04854122 -
Blood Flow Regulation in Individuals With Down Syndrome - Training Study
|
N/A | |
Completed |
NCT04020302 -
Self-Monitoring Shopping Intervention
|
N/A | |
Recruiting |
NCT01950624 -
DS-Connect {TM}: The Down Syndrome Registry
|
||
Completed |
NCT04751136 -
the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
|
Phase 2 | |
Completed |
NCT04767412 -
Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial
|
N/A | |
Not yet recruiting |
NCT04037579 -
Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
|
||
Completed |
NCT04536506 -
Bobath and Vojta Therapy for DS
|
N/A | |
Completed |
NCT02882698 -
Performance Analysis in Down Syndrome on Mobile Phone
|
N/A | |
Completed |
NCT01791725 -
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
|
Phase 2 | |
Unknown status |
NCT01975545 -
Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
|
Phase 2 | |
Completed |
NCT01808508 -
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
|
N/A | |
Terminated |
NCT00754013 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
|
Phase 3 | |
Terminated |
NCT00754052 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
|
Phase 3 | |
Completed |
NCT01256112 -
Parent Supported Weight Reduction in Down Syndrome
|
N/A | |
Completed |
NCT01313325 -
Hippotherapy to Improve the Balance of Children With Movement Disorders
|
N/A | |
Completed |
NCT01594346 -
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
|
Phase 3 | |
Completed |
NCT05343468 -
Life Skills Improved in Children With Down Syndrome After Using Assistive Technology
|
N/A | |
Suspended |
NCT05755464 -
Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
|
||
Recruiting |
NCT04022460 -
Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
|
||
Completed |
NCT04818437 -
Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome
|
N/A |